Opus Genetics (IRD) said that the FDA has granted Fast Track designation for Phentolamine Ophthalmic Solution 0.75% as a ...
FDA Fast Track Designation granted for Phentolamine Ophthalmic Solution 0.75% as treatment of significant chronic night driving impairment in ...
Hosted on MSN4d
Pinellas mother of boy with rare metabolic disorder pushes for more accessible medical foodA Pinellas County mom is pushing for more accessible medical food for her 4-year-old son diagnosed with a rare metabolic disorder.
Opus Genetics (IRD) announced completion of enrollment in the VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback